You have 9 free searches left this month | to do more

gemcitabine

Gemcitabine is a drug used to treat Pancreatic Cancer, Breast Cancer, Bladder Cancer, and other conditions. Gemcitabine is being actively studied in 339 studies and prior, has been studied in 510.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Xian-Jun Yu
Hoffmann-La RocheMemorial Sloan Kettering Cancer CenterJun Ma, MD
M.D. Anderson Cancer CenterMassachusetts General HospitalPD Dr. med. Volker Heinemann
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
2022-03-23
Mar 23, 2022
P
Focused Ultrasound and Gemcitabine in Breast Cancer
Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Gemcitabine
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
2021-10-29
Oct 29, 2021
A
Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients
Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
2021-10-14
Oct 14, 2021
G
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
2021-11-18
Nov 18, 2021
J
Adavosertib and Gemcitabine in Advanced Pancreatic
Not yet recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-01-23
Jan 23, 2022
S
Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma - 2021
Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Madrid, Spain
    Spanish Cooperative for Digestive Tumour Therapy (TTD)
2021-08-11
Aug 11, 2021
R
SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer
Not yet recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
2022-01-10
Jan 10, 2022
H
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) - 2022
Completed
  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
2022-02-10
Feb 10, 2022
D
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
Recruiting
  • Pancreatic Cancer
  • Gemcitabine
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-12-28
Dec 28, 2021
U
Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Gemcitabine
  • Aurora, Colorado
    Children's Hospital Colorado
2022-01-31
Jan 31, 2022
U
Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma - 2020
Completed
  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
2022-02-16
Feb 16, 2022
C
Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer
Recruiting
  • Recurrent Breast Carcinoma
  • +5 more
  • Gemcitabine
  • +4 more
  • Duarte, California
  • +1 more
2022-02-17
Feb 17, 2022
H
Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
Active, not recruiting
  • Unresectable Pancreatic Carcinoma
  • Herlev, Denmark
  • +1 more
2022-03-15
Mar 15, 2022
P
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Not yet recruiting
  • Pancreatic Cancer Metastatic
  • +2 more
  • (no location specified)
2022-02-21
Feb 21, 2022
M
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma or Ewing-Like Sarcoma
Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
2022-03-02
Mar 2, 2022
U
Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
Recruiting
  • Urothelial Cancer of Renal Pelvis
  • Urothelial Carcinoma Ureter
  • sterile water irrigation
  • Gemcitabine
  • Dallas, Texas
    University of Texas Southwestern Medical Center
2021-11-30
Nov 30, 2021
A
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors - 2016
Completed
  • Advanced Solid Tumors
  • veliparib (ABT-888)
  • +2 more
  • (no location specified)
2021-07-29
Jul 29, 2021
S
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
Recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Medical Center
2022-02-03
Feb 3, 2022
J
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Gemcitabine
  • +2 more
  • Beverly Hills, California
  • +1 more
2022-02-07
Feb 7, 2022
V
Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma
Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
2021-12-03
Dec 3, 2021
M
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer
Active, not recruiting
  • Metastatic Urothelial Cancer
  • Baltimore, Maryland
  • +5 more
2021-09-07
Sep 7, 2021
C
Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer
Recruiting
  • Recurrent Pancreatic Cancer
  • Shanghai, China
    Changhai Hospital
2021-05-25
May 25, 2021
S
Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer - 2009
Completed
Has Results
  • Lung Cancer
  • Nashville, Tennessee
    Tennessee Oncology
2022-02-21
Feb 21, 2022
D
Gemcitabine With Ascorbate Including Adolescents
Not yet recruiting
  • Soft Tissue Sarcoma
  • +5 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
2021-12-20
Dec 20, 2021
I
Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors - 2017
Completed
  • Metastatic Solid Tumors
  • Scottsdale, Arizona
  • +1 more
2022-01-27
Jan 27, 2022